These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 8450476)
1. A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes. Echizen H; Kawasaki H; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1993 Mar; 264(3):1425-31. PubMed ID: 8450476 [TBL] [Abstract][Full Text] [Related]
2. Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes. Echizen H; Mochizuki K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1994 Mar; 268(3):1518-25. PubMed ID: 8138963 [TBL] [Abstract][Full Text] [Related]
3. Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients. Masuhara K; Ohno T; Hamaguchi K; Katoh K; Kashiwada K; Takahashi S; Tanaka Y; Someya K; Ogata H Int J Clin Pharmacol Res; 1995; 15(3):103-13. PubMed ID: 8847151 [TBL] [Abstract][Full Text] [Related]
4. Stereoselective disposition and metabolism of disopyramide in pediatric patients. Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088 [TBL] [Abstract][Full Text] [Related]
5. Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals. Jurima-Romet M; Crawford K; Cyr T; Inaba T Drug Metab Dispos; 1994; 22(6):849-57. PubMed ID: 7895601 [TBL] [Abstract][Full Text] [Related]
6. Human pharmacokinetics and metabolism of disopyramide enantiomers. Le Corre P; Gibassier D; Sado P; Le Verge R Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():233-7. PubMed ID: 1820885 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of cyclosporin A. II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes. Bertault-Peres P; Bonfils C; Fabre G; Just S; Cano JP; Maurel P Drug Metab Dispos; 1987; 15(3):391-8. PubMed ID: 2886317 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions. Fabre I; Fabre G; Maurel P; Bertault-Peres P; Cano JP Drug Metab Dispos; 1988; 16(2):296-301. PubMed ID: 2898350 [TBL] [Abstract][Full Text] [Related]
9. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs. Koyama E; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854 [TBL] [Abstract][Full Text] [Related]
10. Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes. Ito K; Ogihara K; Kanamitsu S; Itoh T Drug Metab Dispos; 2003 Jul; 31(7):945-54. PubMed ID: 12814973 [TBL] [Abstract][Full Text] [Related]
11. In vitro assessment of stereoselective hepatic metabolism of disopyramide in humans: comparison with in vivo data. Le Corre P; Ratanasavanh D; Chevanne F; Gibassier D; Sado P; Le Verge R; Guillouzo A Chirality; 1991; 3(5):405-11. PubMed ID: 1756095 [TBL] [Abstract][Full Text] [Related]
12. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver. Amato G; Longo V; Mazzaccaro A; Gervasi PG Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925 [TBL] [Abstract][Full Text] [Related]
13. [Stereoselectivity in N-dealkylation of disopyramide enantiomers in mouse hepatic microsomes]. Kiriyama A; Morita K; Shimakawa H; Yokoyama T Yakugaku Zasshi; 1992 Jan; 112(1):61-4. PubMed ID: 1578345 [TBL] [Abstract][Full Text] [Related]
14. An in vitro study on the metabolism and possible drug interactions of rokitamycin, a macrolide antibiotic, using human liver microsomes. Zhao XJ; Koyama E; Ishizaki T Drug Metab Dispos; 1999 Jul; 27(7):776-85. PubMed ID: 10383920 [TBL] [Abstract][Full Text] [Related]
15. Effect of CYP3A inhibition on vesnarinone metabolism in humans. Wandel C; Lang CC; Cowart DC; Girard AF; Bramer S; Flockhart DA; Wood AJ Clin Pharmacol Ther; 1998 May; 63(5):506-11. PubMed ID: 9630823 [TBL] [Abstract][Full Text] [Related]
16. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies. Daniel WA; Syrek M; Haduch A Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545 [TBL] [Abstract][Full Text] [Related]
17. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans. Le Corre P; Gibassier D; Sado P; Le Verge R Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences. Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151 [TBL] [Abstract][Full Text] [Related]
19. Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data. Yamano K; Yamamoto K; Katashima M; Kotaki H; Takedomi S; Matsuo H; Ohtani H; Sawada Y; Iga T Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):443-52. PubMed ID: 11259329 [TBL] [Abstract][Full Text] [Related]
20. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes. Danie WA; Syrek M; Ryłko Z; Wójcikowski J Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]